2007
DOI: 10.1007/s00210-007-0176-4
|View full text |Cite
|
Sign up to set email alerts
|

α1-Adrenoceptors in proximal segments of tail arteries from control and reserpinised rats

Abstract: It has been recently shown that the supersensitivity of distal segments of the rat tail artery to phenylephrine after chemical sympathectomy with reserpine results from the appearance of alpha(1D)-adrenoceptors. It is known that both alpha(1A)- and alpha(1D)-adrenoceptors are involved in the contractions of proximal portions of the rat tail artery. Therefore, this study investigated whether sympathectomy with reserpine would induce supersensitivity in proximal segments of the rat tail artery, a tissue in which… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 16 publications
0
8
0
Order By: Relevance
“…However, while displacement of [ 3 H]prazosin binding by the a1A-adrenoceptor selective antagonist KMD-3213 was unaffected, the a1D-adrenoceptor selective antagonist, BMY 8378, inhibited high affinity binding of [ 3 H]prazosin in reserpine-pretreated arteries. Increased expression of a1Dadrenoceptors was confirmed by a selective increase in their mRNA (Taki et al, 2004; see also Kamikihara et al, 2007). However, nerve-evoked contractions of the tail artery are almost completely blocked by a1A-adrenoceptor selective antagonists (Sulpizio and Hieble, 1991;Brock and Tripovic, unpublished observations).…”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation
“…However, while displacement of [ 3 H]prazosin binding by the a1A-adrenoceptor selective antagonist KMD-3213 was unaffected, the a1D-adrenoceptor selective antagonist, BMY 8378, inhibited high affinity binding of [ 3 H]prazosin in reserpine-pretreated arteries. Increased expression of a1Dadrenoceptors was confirmed by a selective increase in their mRNA (Taki et al, 2004; see also Kamikihara et al, 2007). However, nerve-evoked contractions of the tail artery are almost completely blocked by a1A-adrenoceptor selective antagonists (Sulpizio and Hieble, 1991;Brock and Tripovic, unpublished observations).…”
Section: Discussionmentioning
confidence: 85%
“…Increased expression of α 1D ‐adrenoceptors was confirmed by a selective increase in their mRNA (Taki et al. , 2004; see also Kamikihara et al. , 2007).…”
Section: Discussionmentioning
confidence: 88%
“…On the other hand, in the more densely innervated smaller resistance arteries, noradrenaline released from sympathetic terminals activates α 1Aadrenoceptors and causes less sustained vasoconstriction allowing rapid vascular tonus adjustment in response to autonomic activation. The positive relationship between the density of adrenergic fibres and dominance of α 1Aadrenoceptors is reversible, as sympathetic denervation increases the expression and participation of the other two subtypes in vasoconstriction (Kamikihara et al, 2005;Kamikihara et al, 2007;Stassen et al, 1998;Taki et al, 2004). In addition, the potencies of antipsychotics in producing orthostatic hypotension correlated with their affinities for α 1Aadrenoceptors but not for α 1Dadrenoceptors (Nourian et al, 2008), as most of the antipsychotics behave as competitive antagonists of α 1 -adrenoceptors, and this positive correlation further indicates that noradrenaline released from sympathetic terminals targets the α 1Aadrenoceptors to increase peripheral vascular resistance.…”
Section: α 1 -Adrenoceptors In Arteriesmentioning
confidence: 99%
“…Sustained overactivation by low dietary levels of natural plant toxins can "turn-off" (deplete) signalling-competent PKC (41) and blunt the contractile response to catecholamines (noradrenaline, adrenaline) and adrenergic agonists like nicotine (37,42). Loss of signal coupling to smooth muscle contractile proteins may initiate a compensatory upregulation of the membrane (adrenergic) receptors that mediate sympathetic vasoconstrictor / pressor reactivity to "re-balance" the system (43), but this may not fully reverse a hypo-contractile / hypo-adrenergic state or restore BP ( Figure 5D-E; Table 1). Of course, mRNA levels are only indicative of transcriptional gene regulation: with limited tissue available we did not show that cotinine down-regulates PKC (and upregulates ADR) proteins.…”
Section: Discussionmentioning
confidence: 99%